Cutera® announces aviclear® investor webinar

Brisbane, calif.--(business wire)--cutera, inc. (nasdaq: cutr), a leading provider of aesthetic and dermatology solutions, announced today that it will hold an investor webinar at 11 a.m. pdt on june 20, 2024, to present an overview of aviclear, the first fda-cleared energy device for the long-term treatment of mild, moderate, and severe inflammatory acne. the webinar will include a review of clinical data, market opportunity, future clinical studies, and real-world user experience. the aviclea.
CUTR Ratings Summary
CUTR Quant Ranking